What is the Westfield Sydney stake sale and who is buying?

Scentre Group is selling a 19.9% interest in Westfield Sydney for A$864 million at book value. The buyer is Australian Retirement Trust, one of Australia’s largest super funds. The deal adds to A$2.2 billion of asset sales since July and targets completion steps into 2026.

Why is the 4.69% cap rate important for investors?

A 4.69% cap rate signals strong pricing and confidence in top-tier CBD retail. It supports book values for prime centres and can steady cap-rate assumptions across the sector. While core assets may hold firm, secondary centres could still see wider yields due to higher risk and leasing needs.

How might the sale affect SCG’s balance sheet and dividends?

Proceeds help reduce debt and improve funding flexibility. That should modestly lower risk and interest costs. Dividends look supported by cash flow, with a yield around 4%. Any growth will depend on leasing outcomes, rental uplifts, and further targeted asset recycling through 2026.

What should traders watch on SCG.AX in the near term?

Key levels include A$4.18 support and A$4.26 to A$4.27 resistance near the 52-week high. Momentum is constructive with RSI near the mid-50s, while ADX shows no strong trend. Upcoming earnings on 25 February 2026 and settlement updates are likely catalysts.

Global Market Insights

SCG.AX Stock Today, January 1: $864m Westfield Sydney Stake Sale

ByHuzaifa Zahoor January 1, 2026January 1, 2026

The Westfield Sydney stake sale is front of mind for Australian investors today. Scentre Group (SCG.AX) agreed to sell 19.9% of Westfield Sydney to Australian Retirement Trust for A$864 million at book value, implying a 4.69% cap rate. Proceeds lift asset sales to A$2.2 billion since July. We explain how this validates prime CBD retail pricing, supports deleveraging, and could shape distributions ahead of a 2026 completion target. We also map key price levels and catalysts to watch for SCG shares in Australia.